Bridgeway Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bridgeway Capital Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-72,500	Closed	-$693K	–	1199
2024 Q4	$693K	Sell	72,500 -40,000	-36%	-$382K	0.02%	746
2024 Q3	$939K	Sell	112,500 -40,000	-26%	-$334K	0.02%	706
2024 Q2	$1.04M	Sell	152,500 -439,433	-74%	-$3M	0.02%	665
2024 Q1	$1.5M	Sell	591,933 -24,524	-4%	-$62K	0.03%	647
2023 Q4	$1.48M	Sell	616,457 -252,148	-29%	-$605K	0.03%	668
2023 Q3	$2.95M	Buy	868,605 +29,172	+3%	+$99.2K	0.07%	420
2023 Q2	$6.17M	Buy	839,433 +34,070	+4%	+$250K	0.15%	218
2023 Q1	$8.34M	Buy	805,363 +542,363	+206%	+$5.62M	0.22%	123
2022 Q4	$3.11M	Sell	263,000 -5,000	-2%	-$59.1K	0.08%	419
2022 Q3	$5.63M	Buy	268,000 +15,000	+6%	+$315K	0.15%	221
2022 Q2	$7.85M	Buy	+253,000	New	+$7.85M	0.18%	192
2019 Q4	–	Sell	-6,700	Closed	-$350K	–	1331
2019 Q3	$350K	Sell	6,700 -7,800	-54%	-$407K	﹤0.01%	1059
2019 Q2	$701K	Buy	14,500 +800	+6%	+$38.7K	0.01%	868
2019 Q1	$692K	Buy	13,700 +3,000	+28%	+$152K	0.01%	897
2018 Q4	$634K	Sell	10,700 -2,300	-18%	-$136K	0.01%	918
2018 Q3	$856K	Hold	13,000	–	–	0.01%	953
2018 Q2	$656K	Sell	13,000 -1,500	-10%	-$75.7K	0.01%	1042
2018 Q1	$763K	Sell	14,500 -2,050	-12%	-$108K	0.01%	937
2017 Q4	$769K	Sell	16,550 -1,450	-8%	-$67.4K	0.01%	946
2017 Q3	$728K	Sell	18,000 -1,900	-10%	-$76.8K	0.01%	964
2017 Q2	$675K	Sell	19,900 -2,000	-9%	-$67.8K	0.01%	984
2017 Q1	$636K	Buy	21,900 +4,200	+24%	+$122K	0.01%	978
2016 Q4	$581K	Sell	17,700 -2,300	-12%	-$75.5K	0.01%	1031
2016 Q3	$631K	Buy	+20,000	New	+$631K	0.01%	978
2016 Q2	–	Sell	-7,650	Closed	-$278K	–	1448
2016 Q1	$278K	Buy	+7,650	New	+$278K	﹤0.01%	1228
2014 Q3	–	Sell	-50,550	Closed	-$1.14M	–	1483
2014 Q2	$1.14M	Buy	50,550 +550	+1%	+$12.3K	0.03%	720
2014 Q1	$1.26M	Hold	50,000	–	–	0.04%	660
2013 Q4	$1.15M	Hold	50,000	–	–	0.04%	692
2013 Q3	$953K	Hold	50,000	–	–	0.03%	746
2013 Q2	$721K	Buy	+50,000	New	+$721K	0.03%	775